»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ 3$tdwe$S
-=="<0c
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨»ù´¡¿Î£©¿ÆÄ¿´úÂ룺806 H}!r|nG
R-:2HRaA
Ò»Ãû´Ê½âÊÍ£¨¹²5Ì⣬ÿÌâ4·Ö£¬¹²20·Ö£© 0sqFF[i
1.Antigen presenting cell£¨APC£© \bF{-" 7.
2.Activation induced cell death£¨AICD£© > I?IPQB
3.Chemokine LLo;\WGZ
4.Major histocompatibility complex£¨MHC£© Ri{=]
$
5.immunotolerance s1rCpzK0
1x)J[fyId
¶þÎÊ´ðÌ⣨¹²5Ì⣬ÿÌâ10·Ö£¬¹²50·Ö£© "[k3kAm
1.ÊÔÊö²ÎÓëThϸ°ûÓëBϸ°ûÏ໥¼¤»îµÄ·Ö×Ó¼°¸÷×ԵŦÄÜ eavV?\uV%
2.ºÎν𤸽·Ö×Ó£¿¼òÊö𤸽·Ö×ӵķÖÀ༰ÆäÔÚÃâÒßÖеÄ×÷Óà -~0^P,yQ
3.¼òÊöIIÐͳ¬Ãô·´Ó¦µÄ·¢Éú»úÖÆ uD'6mk*
4.ÔÚÕý³£Çé¿öÏ£¬ÃâÒßϵͳ¶Ô×ÔÉí¿¹Ô²»²úÉúÃâÒßÓ¦´ðµÄ»úÖÆÊÇʲô£¿ Ey2^?
5.±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã x4 yR8n(
&HW9Jn
ÈýÑ¡´ðÌ⣨µÚ1Ìâ±Ø´ð£¬2ºÍ3ÌâÈÎÑ¡1Ì⣬ÿÌâ15·Ö£¬¹²30·Ö£© +R &gqja
1.¼òÊöÒÆÖ²ÅųⷴӦÖÐÊÜÕßTϸ°û¶ÔͬÖÖÒìÌ忹ԵÄʶ±ð»úÖÆ¡£Í¨¹ýÖ±½Óʶ±ð¼¤»îµÄÊÜÕßThϸ°ûºÍTcϸ°û·Ö±ðÔÚ¸¨ÖúÊÜÕßBϸ°ûºÍɱÉËÒÆÖ²Îï·½ÃæÓë¼ä½Óʶ±ð¼¤»îµÄThºÍTcÓкβîÒ죿Ϊʲô£¿ *T/']t
2.½áºÏÄãµÄרҵÊÔÊöϸ°ûÒò×ÓÔÚ¼²²¡·¢Éú·¢Õ¹ÖеÄ×÷Óã¬Ä㽫²ÉÈ¡ÄÄЩ²ßÂÔÕë¶ÔÕâЩ°ÐµãÖÎÁƼ²²¡£¿ +2{Lh7Ks
3.ºÎΪ»ùÒò¹¤³Ì¿¹Ì壿Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹£¿ rH-23S
%Zi} MPx
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ N['.BN
8=l%5r^cq
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨×¨Òµ¿Î£©¿ÆÄ¿´úÂ룺906 fu5=k:/c
DUS6SO
Ò»Ãû´Ê½âÊÍ£¨4·Ö/Ì⣩ a9gLg
&
1.Antigenic determinant ^sw?gH*
2.IgSF aOp\
91
3.MBL;¾¶ icg
fB-1|i
4.chemokine t_^4`dW`
5.HLA¸´ºÏÌåµÄ¶à»ùÒòÐÔÓë¶àëÄÐÔ )e{aN+
6.TCR-CD3¸´ºÏÎï _/|\aqF.
7.FADD£¨Fas-associated protein with death domain£© d0D]Q
8.AIDS iTwm3V
P
9.Tumor rejection antigen >7|VR:U?B
10.AICD *w&e\i|7
7! Nsm
¶þÎÊ´ðÌ⣨15·Ö/Ì⣩ [JiH\+XLPs
1.¼òÊöCD·Ö×ÓÔÚÃâÒßЧӦÖеÄ×÷Ó㨰´ÊÜÌå·ÖÀà¼òÊö£© qX%_uOw:%
2.¼òÊöBϸ°û²ÎÓëµÄÃâÒß¹¦ÄÜ 0kh6@y3
3.¼òÊö×ÔÉíÃâÒßÐÔ¼²²¡Ê±Õë¶Ô×ÔÉí×éÖ¯²úÉúÃâÒßÓ¦´ðµÄ¿ÉÄÜ»úÖÆ e
,(mR+a8
4.ºÎνͬÖÖÒìÐÍMHC¿¹ÔÖ±½Óʶ±ðºÍ¼ä½Óʶ±ð£¿¼òÊöÆäÒì kVgTGC"L=
.#gzP2 [q
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¶þÄê¹¥¶Á˶ʿÑо¿ÉúÈëѧÊÔÌâ @"A4$`Xi3
afVT~Sf{
[y(MCf19
רҵ¿Î ÃâÒßѧ x5Bk/e'
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê ZK,G
v
1. Immunotoxin 2. T inducer 3. T cell receptor 4. Accessory cell 04ui`-c(
5. Fc¦Å receptor 6. Cytokine /uc>@!F
¶þ¡¢ ÎÊ´ðÌâ B,@i
1. ÃâÒßϵͳÖУ¬ÄÄЩϸ°ûÄÜÌØÒì»ò·ÇÌØÒâÐÔµØÉ±É˰Ðϸ°û£¬ÊÔ·Ö±ð¼òÊöɱÉË×÷ÓõIJ»Í¬Ìص㡣 ?<!|
2. ¸ù¾ÝT¡¢Bϸ°û±íÃæ±êÖ¾µÄ²»Í¬£¬¿ÉÒÔÓ¦ÓÃÄÄЩÃâÒßѧ¼¼Êõ¼ø±ðÕâÁ½Ààϸ°û£¬¼òÊöÓйصÄʵÑéÔÀí£¿ Q &8
-\
3. ÔÚIVÐͳ¬Ãô·´Ó¦ÖУ¬ÖÂÃôTϸ°ûÊÍ·ÅÄÄЩÁܰÍÒò×Ó²ÎÓëÃâÒßËðÉË£¬ÏêÊöÆä×÷ÓûúÀí¡£ 7CysfBF0g
4. ÊÔÊöHLA¸´ºÏÌåµÄÒÅ´«Ìص㼰ÕâÐ©ÌØµãµÄÉúÎïѧÒâÒ壿 ES[G
5. ºÎνµ¥¿Ë¡¿¹Ì壿ÏêÊöÆäÔÚ»ù´¡ÓëÁÙ´²Ò½Ñ§ÖеÄÓ¦Óᣠ/~1+i'7V.,
4#D,?eA7
/ZX}Nc g
m67V_s,7B
Z,gk|M3.
203s^K61
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÈýÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ 43c
E`9~
!
nx{
X
?ub35NLa
רҵ¿Î ÃâÒßѧ 5P bW[
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê [),ige
1¡¢ Complement receptor type ¢ñ 2¡¢ Serologically defined antigen Cp N>p.kM
3¡¢ Transfer factor 4¡¢ Immunotoxin 5¡¢ Perforin e-;}366}
6¡¢ Arthus reaction 7¡¢ Network theoty 8.Lymphocyte transformation test V`5O{Gg
9. Hybridoma technic 10.Mitogen )J |6 -C
11.Dentritic cell 12.Immunoproliferation rv;3~'V
¶þ¡¢ »Ø´ðÏÂÁÐÎÊÌâ ceA9){
1¡¢ ÍÌÊÉϸ°û¶Ôϸ¾úµÄÍÌÊɹý³Ì°üÀ¨ÄöÖ÷Òª½×¶Î£¬ÊÔÏêÊöÖ®¡£ Om&Dw|xG8
2¡¢ ÊÔÊöIL-2µÄϸ°ûÀ´Ô´¹¦Äܼ°ÁÙ´²Ó¦ÓᣠRi'n
3¡¢ Ò©Îï»ò»¯Ñ§ÊÔ¼ÁÒýÆðµÄÒ©ÕîÊôÓÚʲôÐͳ¬Ãô·´Ó¦£¬ÊÔÊöÆä»úÀí¡£ !D6]JPX
4¡¢ ÌåÄÚµÄÃâÒß·Ö×Ó°üÀ¨Äļ¸ÀࣿÊÔ¼òÊö¸÷ÀàÃâÒß·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡£ iZ%yd-
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¿ÊÔ·Ö±ð¼òÊöËüÃǵÄÖ÷ÒªÔÀí¡£ gw(z1L5
n
<@}9Bid!o
XW9!p.*.U
~&O%N
}]TxlSp!;
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅËÄÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ +\'t
E~V
Ac6=(B
g0H[*"hj
רҵ¿Î ÃâÒßѧ ^Cmyx3O^
Ò»¡¢ Ãû´Ê½âÊÍ E^PB)D(.
1¡¢ ³Ù·¢Ðͱä̬·´Ó¦Tϸ°û 2¡¢ C1ÒÖÖÆÎï oU|c.mYe
3¡¢ ¼¯Âä´Ì¼¤Òò×Ó 4¡¢ ¿¹ÔÌá³Ê×÷Óà B!yr!DWv
5¡¢ HIAÓë¼²²¡µÄ¹ØÁª 6¡¢ Ë«¹¦ÄÜ¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ ^8tEach
¶þ¡¢ ÎÊ´ðÌâ )"LJ
hLg
1¡¢ TÁܰÍϸ°û¾ßÓÐÄÄЩ±íÃæ±êÖ¾£¿ÊÔÊö¸÷±íÃæ±êÖ¾µÄÉúÎïѧ×÷Óü°/»òÒâÒå¡£ NI5``BwpO
2¡¢ ÊÔÊöÒÆÖ²ÅųⷴӦµÄÃâÒßÓ¦´ð¹ý³Ì¼°²ÎÓëÅųⷴӦµÄÖÂÃôÁܰÍϸ°ûºÍЧӦÎïÖÊ¡£
+p^u^a
3¡¢ ºÎνϸ°ûÒò×Ó£¿¼òÊöÆä¹²Í¬Ìص㼰ÓëÁÙ´²µÄ¹ØÏµ¡£ "b[5]Y{
U
4¡¢ ºÎνÁܰÍϸ°ûÔÓ½»Áö¼¼Êõ£¬ÊÔÊöÆäÔÀí¼°ÒâÒå¡£ <VcQ{
F
5¡¢ ºÎνÉúÎïËØ-Ç׺ÍËØÏµÍ³£¿ÊÔÊöÆäÓ¦ÓÃÓÚÃâÒß±ê¼Ç¼¼ÊõµÄÔÀí£¬ÒÔABC·¨ÎªÀý˵Ã÷Ö®¡£ Q\)F;: |
BY*Q_Et
\jA~9
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÎåÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ !BI;C(,RL
u>$t'
%SI'BJ
רҵ¿Î ÃâÒßѧ z2c6T.1M
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê *A< 5*Db:F
1¡¢ SmIg 2¡¢ Graft-versus-host reaction GVHR '|4!5)/K
3¡¢ Immunocompent cell ICC 4¡¢ Tumor-associated antigen TAA :]c3|J
5¡¢ Cytokine 6¡¢ Immune tolerance 7¡¢ Biological responsw modifier BRM
Wm|lSisY
¶þ¡¢ ÎÊ´ðÌâ R3!t$5HG
1¡¢ ÃâÒßϵͳÄÚÆðɱÉËЧӦµÄϸ°ûÓÐÄÄЩ£¿ÊÔ¼òÊöÆäɱÉËЧӦµÄÌØµã¡£ p7Cs.2>M>S
2¡¢ ºÎν¿¹ÌåµÄ¶àÑùÐÔ£¿¿¹ÌåµÄ¶àÑùÐÔ±íÏÖÔÚÄÄЩ·½Ã棿¼òÊö²úÉú¿¹Ìå¶àÑùÐÔµÄÔÀí¡£ GL JMP^p
3¡¢ ÊÔÊö¢òÐÍÓë¢óÐͳ¬Ãô·´Ó¦·¢Éú»úÖÆµÄÒìͬµã¡£ ccnK#fn v
4¡¢ ºÎνMHC£¿ÊÔ¼òÊöÆä¹¦ÄÜ¡£ /> Nt[o[r
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¬ÒÔø±ê¼Ç¼¼ÊõΪÀý¼òÊöÆäÖ÷ÒªÔÀí¡£ P$sxr
)i<j XZ:O
nie% eC&U
fLVAKn
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÁùÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ |' .
i&k7-<
P&q7|ST%N
רҵ¿Î ÃâÒßѧ |M_UQ
QAB|
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê _wOt39e&
1. IgSF 2. Fc 3. Flow cytometry 4. Adhesion molecule '!$%> ||S
5. Autogous mixed lymphoyte reaction ;wVwX6:ZKr
¶þ¡¢ ÎÊ´ðÌâ rH>)oThA#
1. ÊÔÊöÍâÀ´TD¿¹Ô½øÈë»úÌåÓÕµ¼¿¹Ìå²úÉúµÄÈ«¹ý³Ì¡£ X(C$@N
2. ºÎνϸ°ûÒò×Ó£¿¼òÊöIL-2µÄ¼ì²â·½·¨¼°ÆäÔÀí¡£ T)CP2U
3. ¼òÊö¿¹¶ÀÌØÐÍÍøÂçµÄµ÷¿Ø×÷Óᣠ%bfZn9_m
4. ÃâÒßÓ¦´ð¶Ô»úÌåÓкÎÀûº¦¹ØÏµ£¿ 8V(pugJ
<t,x RBk
ETLD$=iS
# [a*rD%m
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÆßÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ 'RRE|L,
z] Ue|%K
:Yks|VJ1
רҵ¿Î ÃâÒßѧ qw8Rlws%
03(4 x'z
6R5Qy]]E
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê LDD|(KLR*.
1. Idiotupe 2. Opsonization 3. Epitope 4. Immunologic tolerance l+R+&b^
5. Delayed type hypersensitivity N?>vd*
¶þ¡¢ ÎÊ´ðÌâ Faf&U%]*`
1. ÊÔÊö²¹Ì徵伤»î;¾¶ÓëÅÔ·¼¤»î;¾¶µÄÒìͬ¡£ Z<4AL\l 98
2. ¼òÊö¿¹ÌåµÄ»ù±¾½á¹¹£¨ÒÔIgGΪÀý£©Ó빦ÄÜ¡£ Q^(b)>?r;
3. ¼òÊöHLAÓëҽѧµÄ¹ØÏµ¡£ 7=DdrG<
4. ÊÔÊöµ¥ºË/¾ÞÊÉϸ°ûÔÚÃâÒßÓ¦´ðÖеÄ×÷Óᣠ:h V7>
rr
5. ¼òÊöÃâÒßÓ¦´ðÖи÷ÖÖÀàÐ͵Äϸ°û¶¾×÷ÓᣠP2*<GjV`S/
g4@ lM"|S
,=:D
T5:G$-qL(
B+0hzkPY
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å°ËÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ 4g7)i L^#~
l$'wD hN*
5 BJmA2L
רҵ¿Î ÃâÒßѧ ->{KVPHe{
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê S[T8T|_
1. hypersensitivity 2. cluster of differentiation Z`BK/:vo3H
3. adhesion molecules 4. supper antigen 5. split tolerance y|q3Wa
¶þ¡¢ ÎÊ´ðÌâ -o.:P>/
1. ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ÓµÄÖ÷ÒªÉúÎïѧ»îÐÔ¡£ Y)a^(!<H<
2. ¼òÊöMHC¿¹ÔµÄ·Ö×ӽṹ¼°Æä×éÖ¯·Ö²¼¡£ vA.MRu#
3. ÊÔÊöÐØÏÙÒÀÀµÐÔ¿¹ÔÒýÆðÌåÒºÃâÒßÓ¦´ðµÄÈ«¹ý³Ì£¨°üÀ¨³õ´ÎÃâÒßÓ¦´ðºÍÔÙ´ÎÃâÒßÓ¦´ð£©¡£ v 6Vcjm
4. Ϊʲô˵²¹Ì弤»î;¾¶Ö÷Òª²ÎÓëÌìÈ»ÃâÒߣ¿ÊÔÊö²¹ÌåÊÇÈçºÎ¾¹ýÅÔ·;¾¶¶ø±»¼¤»îµÄ¡£ e NafpK
5. Ϊʲô¿¹Ä³Ò»Ï¸°ûÒò×ÓÊÜÌåµÄµ¥¿Ë¡¿¹ÔÌ壬ÓбíÏÖ³öÊÜÌå·â±Õ×÷Ó㬶øÓеÄÔò±íÏÖ³öÊÜÌå´Ì¼¤×÷Óã¿ 'XBFv9&
?KI,cl
>6pf$0
SC])?h-Fw
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ 0,8okAH
רҵ¿Î ÃâÒßѧ "v4B5:bmqW
Ò»¡¢ Ãû´Ê½âÊÍ u=_mvN
1. ¿¹ÔÐÔ 2. ÃâÒßÇòµ°°×³¬¼Ò×å 3. ¶ÀÌØÐÍ 4. ¿¹Ô¾ö¶¨×å C=4Qlt[`
5. GVHR .q 3/_*
¶þ¡¢ ÎÊ´ðÌâ ^Js9 s8?$
1. Á½ÖÖ²¹Ì弤»î;¾¶µÄµ÷½ÚÒò×ÓÓÐÄÄЩ£¿±È½ÏËüÃÇÁ½ÖÖ;¾¶ÖеÄ×÷Óᣠ[\b0Lem
2. ¢òÐͳ¬Ãô·´Ó¦µÄ»úÀíÌØµãÊÇʲô£¿¾Ù³öÈý¸ö¢òÐͳ¬Ãô·´Ó¦µÄÀý×Ó¡£ E1U",CMU
3. ÊÔÊöϸ°ûÒò×ÓµÄ×÷ÓÃÌØµã¡£ \K<QmK
4. Bcell½éµ¼µÄÌåÒºÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ fe#\TNeQJ[
5. MPSµÄÃâÒßѧ¹¦ÄÜ¡£ QS]1daMIK<
kd$D 3S^{
5j-YM
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ ;
p {[1
?_"ik[w}
M>8A\;"
רҵ¿Î ÃâÒßѧ JOim3(5?s
Ò»¡¢Ãû´Ê½âÊÍ ~PahoRS
1. ÃâÒßÇòµ°°×µÄ¶ÀÌØÐÍ 2. 𤸽·Ö×Ó 3. ÃâÒßÇòµ°°×³¬¼Ò×å 1,!(0
5H
4. ¸ÉÈÅËØ 5. HLAµÄ¶à̬ÐÔ 6. ÐØÏÙÒÀÀµÐÔ¿¹Ô 7. ÃâÒßÄÍÊÜ 9
ea\vZ
8. ËÙ·¢Ðͳ¬Ãô·´Ó¦ 9. µ¥¿Ë¡¿¹Ìå 10. ²¹Ì徵伤»î;¾¶ :7?FF'u
11. »ìºÏÁܰÍϸ°û·´Ó¦ 12. ÓÐË¿·ÖÁÑ ["e3Ez
Èý¡¢ ÎÊ´ðÌâ PO7Lf#9]
1. ÊÔ¼òÊö¾ÞÊÉϸ°ûÌá³ÊTD¿¹ÔµÄ¹ý³Ì¡£ P0PWJ^+,+
2. ÊÔ¼òÊöÒÆÖ²ÎËÞÖ÷·´Ó¦µÄ·¢Éú»úÖÆ o W Nh@C
3. ÊÔÊö²¹ÌåµÄÖ÷ÒªÉúÎïѧ×÷Óà \1 &,|\E#
4. ÒÔIgGΪÀý£¬ÊÔÊöÃâÒßÇòµ°°×·Ö×ӵĻù±¾½á¹¹ h"lv7;B$
5. ÊÔÊöTϸ°ûµÄÖ÷Òª±íÃæ±êÖ¾¼°¹¦ÄÜ pWsDzb6?%
2nIw7>.}f
/U)D5ot<
*zL}&RUKM
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ !|S43i&p
k<{{*
M|`U"vO
רҵ¿Î ÃâÒßѧ JU5C}%Q6
Ò»¡¢Ãû´Ê½âÊÍ Y@ksQ_u
1. Ig¶ÀÌØÐÍ 2. SAg 3. 𤸽·Ö×Ó 4. CSF 5. IgSF 6. Tϸ°û»î»¯µÄ´Ì¼¤·Ö×Ó xZwLlY
7. HLAÓë¼²²¡µÄ¹ØÁª 8. ELISA 9. ÁܰÍϸ°ûµÄ±íÃæ±êÖ¾ 2M'[,Xe
Èý¡¢ ÎÊ´ðÌâ 7.#F,Ue_0T
1. ¼òÊöTÁܰÍϸ°ûµÄ·ÖÀ༰¹¦ÄÜ£¿ Pjjewy1}
^
2. ¼òÊöHLAÍ»±äÌåµÄ»ùÒò×é³É¼°HLAµÄ¹¦ÄÜ£¿ iv;Is[<o
3. ¼òÊö»úÌå¶ÔÍâÔ´ÐÔ¿¹Ô£¨ÒìÎԣ©µÄ´¦Àí£¬ÈçIgÌá³Ê¹ý³Ì£¿ ],a 5)kV
4. ¼òÊö²¹ÌåÁ½ÖÖ¼¤»î;¾¶µÄ»ù±¾¹ý³Ì£¬²¢±È½Ï¶þÕßÒìͬ£¿ QKN+>X
5. ¼òÊöAIDSÖÐCD4+ϸ°û¼õÉٵĻúÖÆ£¿ usCt#eZK
b8SHg^}
tL)
t" i
q$tUH)0
Ww%=1M]e-
99Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ r^paD2&}
Ò»¡¢Ãû´Ê½âÊÍ JYd 'Jp8bP
2¡¢ HLAµÄ¶à̬ÐÔ 3¡¢ 𤸽·Ö×Ó 4¡¢ ¶ÀÌØÐÍ 5¡¢ ¿¹ÔëÄתÔËÎï ?
!cvf{a
6¡¢ Ig³¬¼Ò×å 7¡¢ µòÍö 8¡¢ ÓÐË¿·ÖÁÑÔ 9¡¢ CD4·Ö×Ó iQ
fJ
10¡¢ ³¬Ãô·´Ó¦ 11¡¢ ×ÔÉíÃâÒß²¡ A}N?/{y)G
¶þ¡¢ ÎÊ´ðÌâ a$" Hvrj
1¡¢ ÊÔÊöÍâÔ´ÐÔ¿¹ÔºÍÄÚÔ´ÐÔ¿¹ÔÌá³ÊµÄ¹ý³Ì¡£ 72y0/FJ
2¡¢ ÊÔÊöBϸ°û½éµ¼µÄÔÙ´ÎÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ FrYqaP
3¡¢ ÊÔÊö·Ö×ÓˮƽµÄÃâÒßµ÷½Ú¡£ u TK,&
4¡¢ ÊÔÊö»ñµÃÐÔÃâÒßȱÏÝ×ÛºÏÕ÷£¨AIDS£©µÄ·¢²¡»úÖÆ¡£ e`TH91@
DB:+E|vSD
2000Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ s<_)$}
Ò»¡¢ Ãû´Ê½âÊÍ \$\ENQ
;Nk
1¡¢ µ÷Àí×÷Óà 2¡¢ 𤸽·Ö×Ó 3¡¢ ³¬¿¹Ô 4¡¢ ÃâÒßȱÏݲ¡ CcFn.omA
5¡¢ FasÓëFasL 6¡¢ µ¥¿Ë¡¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ .my0|4CQ#@
8¡¢ ÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£© 9¡¢ Ö×ÁöÏà¹Ø¿¹Ô£¨TAA£© T
DNQu_E
10¡¢ ÒõÐÔÑ¡Ôñ
B$!)YD;
¶þ¡¢ ÎÊ´ðÌâ VG5+CU
1¡¢ ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ӵĹ²Í¬Ìص㣿 Vz)`nmO}5\
2¡¢ ºÎνAPC¼°ÆäÖÖÀࣿ¼òÊöÍâÔ´ÐÔ¿¹ÔµÄÈÜøÌåÌá³Ê;¾¶£¿ 3`.7<f`
3¡¢ ¼òÊöϸ°ûÃâÒßÓ¦´ðµÄÁ½ÀàЧӦϸ°ûµÄЧӦ»úÖÆ£¿Ï¸°ûÃâÒßµÄÉúÎïѧÒâÒ壿 7-T{a<g
4¡¢ ºÎνMHC£¿¼òÊöMHCµÄ¹¦ÄÜ£¿ )
Es"LP]
5¡¢ ºÎν×ÔÉíÃâÒß²¡£¿¼òÊö×ÔÉíÃâÒß²¡µÄ×éÖ¯ËðÉË»úÖÆ£¿. M|qteo
&L
Vn6zAba
s,n0jix@
!l 1fIc
ͬ¼ÃÒ½¿Æ´óѧ2000Äê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ mkF"
(+3Wgl+]/
1ilBz9x*!
רҵ¿Î ÃâÒßѧ [4C:r!
Ò»¡¢½«ÏÂÁÐÓ¢Óïµ¥´Ê·Òë³ÉÖÐÎIJ¢Ãû´Ê½âÊÍ rKf-+6Na
1. Cytokines 2. adhesion molecules 3. graft versus host reaction B'EKM)dA
4. immunologic tolerance 5. Opsonization C@W"yYt
Èý¡¢ ÎÊ´ðÌâ &2zq%((r
1. ʲôÊÇMHC£¿ÊÔÊöMHC-¢òÀà·Ö×ӵĽṹ¡¢¸÷²¿Î»¹¦ÄÜ£¬MHC-¢òÀà·Ö×ÓµÄ×éÖ¯·Ö²¼¼°ÆäÃâÒßѧ×÷ÓᣠuVDa^+=
2. ÓÐÄÄÈý´ú¿¹Ì壿ÊÔÊö¿¹Ì壨IgG£©µÄ»ù±¾½á¹¹¡¢¸÷²¿Î»¹¦Äܼ°ÕâÈý´ú¿¹ÌåµÄÌØÐÔ¡£ !PJ 6%"
3. ʲôÊÇ×ÔÉíÃâÒß²¡£¿ÊÔÊöÆä·¢²¡»úÖÆ¡£ +H#U~p$
4. ÃâÒßϵͳɱÉ˰Ðϸ°ûµÄ·½Ê½¼°ÏàӦϸ°ûºÍ·Ö×ÓÓÐÄÄЩ£¿ÊÔÊöTc½éµ¼µÄϸ°ûÃâÒßÓ¦´ð¡£ :WL'cJ9a
5. »úÌåµÄÃâÒßϵͳΪʲô¿ÉÒÔʶ±ð×Ô¼ººÍÒ켺£¿ÆäÖ÷Òª»úÖÆÊÇʲô£¿ -'BA{#e}L
(RZD'U/B
e0@Y#7N62
,
NVsn
$Gv9m
x61 U[/r
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ A\#P*+k 0
%v7[[U{T
?6jkI2w
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧרҵ¿Î¿¼ÊÔÊÔÌâ ~Oq +IA~9
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ i?:_:"^x
Ò»¡¢ ½âÊÍÏÂÁÐÃû´Ê >P $;79<
1. C3b½éµ¼µÄµ÷Àí×÷Óà 2.Tϸ°û¼¤»îµÄµÚ¶þÐźÅ3.Th1ϸ°û 4.HLAµÄ¶à̬ÐÔ y>|{YWbp?
5.C1ÒÖÖÆÎï 6.TCR¦Ã¦ÄTϸ°û7.³Ù·¢Ðͳ¬Ãô·´Ó¦ 8.Ç÷»¯ÐÔϸ°ûÒò×Ó9.ÃâÒßÇòµ°°×µÄÀà±ðת»¯ 10.ÔìѪ¸Éϸ°û njnDW~Snb
11.»î»¯ÓÕµ¼µÄϸ°ûËÀÍö T%n2$
¶þ¡¢ Çë»Ø´ðÏÂÁÐÎÊ´ð @b~fIW_3>
1. ºÎνµ¥¿Ë¡¿¹Ì壬¼òÊöÆäÖÆ±¸ÔÀí¡£ 0#*#a13
2. ¼òÊöTϸ°ûÔÚÐØÏÙÄڵķ¢Óý¹ý³Ì¡£ ,qrQ"r9
3. ÃâÒßϸ°û±íÃæÖ÷ÒªÓÐÄļ¸Àà±íÃæ¿¹ÔºÍ±íÃæÊÜÌ壬¼òÊö¸÷Àà·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡££¨HLA¡¢CD¡¢AM¡¢CKR¡¢CR¡¢MitogenR¡¢TCR¡¢BCR¡¢FcR£© VA%Un,5h
4. ÊԱȽÏTCR¸´ºÏÌåºÍBCR¸´ºÏÌå½á¹¹Ó빦ÄܵÄÒìͬ¡£ j$Je6zq0x
5. ÊԱȽϳ¬¿¹ÔÓëÆÕͨ¿¹ÔµÄÒìͬ¡£ $gM8{.!
`VL}.h
.rJiyED?!
-TOI c%
(%:>T
Q(
t/PlcV_M"
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ d/e|'MPX
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧµ¥¶À¿¼ÊÔÊÔÌâ j]m|7]
¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ F5qFYL;
}Lw>I94e
Ò»¡¢ Ãû´Ê½âÊÍ >xn}N6Rj2~
1. ¿¹Ô³ÊµÝ 2. µ÷Àí×÷Óà 3. ³Áµí·´Ó¦ 4. ×ÔÉíÃâÒß n%\
/J
5. GVHR 6. ÔìѪ¸Éϸ°û 7. ¿Ë¡ѡÔñѧ˵ 8. Ir»ùÒò ([VV%ovZ
9. ³¬Ãô·´Ó¦ 10. ³¬¿¹Ô wB{;bB{
¶þ¡¢ÎÊ´ðÌâ ^+9sG$T_EV
11. ¼òÊö²¹ÌåµÄÅÔ·¼¤»î;¾¶ o!r8{L
12. ¼òÊöT¡¢Bϸ°ûÌØÕ÷µÄ²îÒì
E|$Oha[
13. ¼òÊöT¡¢Bϸ°û¿¹Ô¾ö¶¨´ØµÄ²îÒì Mf#83<&K
14. ΪʲôÃâÒßÇòµ°°×¾ßÓп¹ÔÐÔ£¿ÊÔÊöÃâÒßÇòµ°°×µÄ¿¹ÔÐÔ¡£ W Qc>
15. ʲôÊÇÖ×Áö¿¹Ô£¿ÊÔÊö»úÌåÕë¶ÔÖ×Áö¿¹Ô²úÉú¿¹Ö×ÁöÃâÒßÓ¦´ðµÄ»úÖÆ¡£ gxGrspqg
U70]!EaT